Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure).
about
Pharmacological Treatment of Heart Failure with Preserved Ejection FractionA nurse-led up-titration clinic improves chronic heart failure optimization of beta-adrenergic receptor blocking therapy--a randomized controlled trialPatterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization.Gaps in Medical and Device Therapy for Patients with Left Ventricular Systolic Dysfunction: The EchoGap Study.Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial.Factors associated with β-blocker initiation and discontinuation in a population-based cohort of seniors newly diagnosed with heart failure.Chronic heart failure: we are fighting the battle, but are we winning the war?Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial.The gap between clinical trials and clinical practice: the use of pragmatic clinical trials to inform regulatory decision making.Traditional heart failure medications and sudden cardiac death prevention: a review.Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial.The use of guideline recommended beta-blocker therapy in primary prevention implantable cardioverter defibrillator patients: insight from Danish nationwide registers.Does prearrest adrenergic integrity affect pressor response? A comparison of epinephrine and vasopressin in a spontaneous ventricular fibrillation swine model.Ivabradine in heart failure: hope or hype?Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT).Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry.Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF).Effects of intravenous and oral β-blockade in persistent asthmatics controlled on inhaled corticosteroids.Clinical tolerability of generic versus brand beta blockers in heart failure with reduced left ventricular ejection fraction: a retrospective cohort from heart failure clinic.Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study
P2860
Q33885952-47240D48-7954-4D57-9F19-739C6D11C564Q34278582-136FB292-36A1-4484-962E-24B0AA9DA371Q34307931-F974739C-68F9-4238-BBF1-2D66D85CB897Q34384769-062E9A1D-46BC-4701-8CD8-AEDAFC3E4359Q36094884-35684BC7-8C48-4E9E-B158-CCE0FEFE223FQ37269746-EF38744F-FD01-4ACA-B103-71914D7977A5Q37288386-CE03ACB0-8552-43CD-B282-6B855118FAAAQ37394083-CA4B3EAD-687F-4670-942B-36C3DEB05A88Q37654695-0A83AE18-8EF1-4F90-8481-105CE02BC6E3Q38114415-06833CC3-87AE-4242-9AE1-8B439BCBDC11Q39024503-B276B025-54CF-469C-8D88-0A038B0BF09DQ40275436-57C2B0A4-CE0A-43AB-A008-A7C1C121E4B4Q41788393-551E0478-20E3-401D-BAB2-0461154CA79EQ42697471-8E40A6AA-8D6C-4BE3-837A-F91246270281Q43247698-A3EBC110-1B55-4B66-AF20-C0F8D1A2D40BQ44887473-2D0F8AEE-06A7-4ABE-ACDE-F17B4DB363FDQ45835594-B202B9C8-917D-45AD-AC30-94F39020EC01Q45950168-D6DC328C-9168-42E1-A4BE-C0CE02E14D7AQ49591511-92E28ECA-1A40-429C-8EE0-4BA96F960A06Q59136323-04088F28-D4D9-4EE2-B9E9-7F1CB06EE510
P2860
Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure).
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Dosing of beta-blocker therapy ...... Patients with Heart Failure).
@en
Dosing of beta-blocker therapy ...... Patients with Heart Failure).
@nl
type
label
Dosing of beta-blocker therapy ...... Patients with Heart Failure).
@en
Dosing of beta-blocker therapy ...... Patients with Heart Failure).
@nl
prefLabel
Dosing of beta-blocker therapy ...... Patients with Heart Failure).
@en
Dosing of beta-blocker therapy ...... Patients with Heart Failure).
@nl
P2093
P50
P1476
Dosing of beta-blocker therapy ...... Patients with Heart Failure).
@en
P2093
Barry H Greenberg
James B Young
Jie Lena Sun
Nancy M Albert
William T Abraham
P304
P356
10.1016/J.AMJCARD.2008.07.045
P407
P577
2008-09-06T00:00:00Z